For help on how to get the results you want, see our search tips.
1210 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Referrals Remove Referrals filter
Periodic safety update report single assessments Remove Periodic safety update report single assessments filter
Categories
Human Remove Human filter
Authorisation status
Authorised Remove Authorised filter
-
List item
Human medicine European public assessment report (EPAR): Vaxchora (updated)
vibrio cholerae, strain cvd 103-hgr, live, Cholera
Date of authorisation: 01/04/2020,
, Revision: 2, Authorised, Last updated: 07/04/2021
-
List item
Human medicine European public assessment report (EPAR): Cimzia (updated)
Certolizumab pegol, Arthritis, Rheumatoid
Date of authorisation: 01/10/2009, Revision: 30, Authorised, Last updated: 07/04/2021 -
List item
Human medicine European public assessment report (EPAR): Competact (updated)
pioglitazone, metformin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 28/07/2006, Revision: 19, Authorised, Last updated: 07/04/2021 -
List item
Human medicine European public assessment report (EPAR): Bemrist Breezhaler (updated)
indacaterol, Mometasone furoate, Asthma
Date of authorisation: 30/05/2020, Revision: 1, Authorised, Last updated: 07/04/2021 -
List item
Human medicine European public assessment report (EPAR): Kisplyx (updated)
lenvatinib mesilate, Carcinoma, Renal Cell
Date of authorisation: 25/08/2016,, 
, Revision: 13, Authorised, Last updated: 07/04/2021
-
List item
Human medicine European public assessment report (EPAR): Tysabri (updated)
natalizumab, Multiple Sclerosis
Date of authorisation: 27/06/2006, Revision: 33, Authorised, Last updated: 06/04/2021 -
List item
Human medicine European public assessment report (EPAR): Inbrija (updated)
levodopa, Parkinson Disease
Date of authorisation: 19/09/2019, Revision: 2, Authorised, Last updated: 06/04/2021 -
List item
Human medicine European public assessment report (EPAR): Pemetrexed Hospira (updated)
pemetrexed, Carcinoma, Non-Small-Cell Lung, Mesothelioma
Date of authorisation: 19/11/2015,
, Revision: 11, Authorised, Last updated: 06/04/2021
-
List item
Human medicine European public assessment report (EPAR): Exviera (updated)
dasabuvir sodium, Hepatitis C, Chronic
Date of authorisation: 14/01/2015,, , Revision: 19, Authorised, Last updated: 06/04/2021
-
List item
Human medicine European public assessment report (EPAR): Cresemba (updated)
isavuconazole, Aspergillosis
Date of authorisation: 15/10/2015,
, Revision: 10, Authorised, Last updated: 06/04/2021
-
List item
Human medicine European public assessment report (EPAR): Aybintio (updated)
bevacizumab, Colorectal Neoplasms, Breast Neoplasms, Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms
Date of authorisation: 19/08/2020,, 
, Revision: 2, Authorised, Last updated: 06/04/2021
-
List item
Human medicine European public assessment report (EPAR): Truvada (updated)
emtricitabine, tenofovir disoproxil fumarate, HIV Infections
Date of authorisation: 20/02/2005, Revision: 44, Authorised, Last updated: 31/03/2021 -
List item
Human medicine European public assessment report (EPAR): Incresync (updated)
alogliptin, pioglitazone, Diabetes Mellitus, Type 2
Date of authorisation: 19/09/2013, Revision: 9, Authorised, Last updated: 31/03/2021 -
List item
Human medicine European public assessment report (EPAR): Vipidia (updated)
alogliptin, Diabetes Mellitus, Type 2
Date of authorisation: 18/09/2013, Revision: 5, Authorised, Last updated: 31/03/2021 -
List item
Human medicine European public assessment report (EPAR): Ivozall (updated)
clofarabine, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation: 14/11/2019,, Revision: 2, Authorised, Last updated: 31/03/2021
-
List item
Human medicine European public assessment report (EPAR): Fycompa (updated)
perampanel, Epilepsies, Partial
Date of authorisation: 23/07/2012, Revision: 20, Authorised, Last updated: 31/03/2021 -
List item
Human medicine European public assessment report (EPAR): Keytruda (updated)
Pembrolizumab, Melanoma, Hodgkin Disease, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Urologic Neoplasms, Squamous Cell Carcinoma of Head and Neck
Date of authorisation: 17/07/2015,, Revision: 32, Authorised, Last updated: 31/03/2021
-
List item
Human medicine European public assessment report (EPAR): Alli (previously Orlistat GSK) (updated)
orlistat, Obesity
Date of authorisation: 22/07/2007, Revision: 17, Authorised, Last updated: 31/03/2021 -
List item
Human medicine European public assessment report (EPAR): Repatha (updated)
Evolocumab, Dyslipidemias, Hypercholesterolemia
Date of authorisation: 17/07/2015, Revision: 17, Authorised, Last updated: 31/03/2021 -
List item
Human medicine European public assessment report (EPAR): Levetiracetam Teva (updated)
levetiracetam, Epilepsy
Date of authorisation: 25/08/2011,, Revision: 17, Authorised, Last updated: 31/03/2021
-
List item
Human medicine European public assessment report (EPAR): Amyvid (updated)
florbetapir (18F), Radionuclide Imaging
Date of authorisation: 14/01/2013, Revision: 14, Authorised, Last updated: 31/03/2021 -
List item
Human medicine European public assessment report (EPAR): Matever (updated)
levetiracetam, Epilepsy
Date of authorisation: 03/10/2011,, Revision: 22, Authorised, Last updated: 31/03/2021
-
List item
Human medicine European public assessment report (EPAR): Pioglitazone Teva Pharma (updated)
pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 26/03/2012,, Revision: 12, Authorised, Last updated: 31/03/2021
-
List item
Human medicine European public assessment report (EPAR): Lenalidomide Mylan (updated)
lenalidomide, Multiple Myeloma
Date of authorisation: 18/12/2020,, Revision: 1, Authorised, Last updated: 31/03/2021
-
List item
Human medicine European public assessment report (EPAR): Zelboraf (updated)
vemurafenib, Melanoma
Date of authorisation: 17/02/2012, Revision: 20, Authorised, Last updated: 31/03/2021